PuSH - Publikationsserver des Helmholtz Zentrums München

Crotti, L. ; Marcou, C.A.* ; Tester, D.J.* ; Castelletti, S.* ; Giudicessi, J.R.* ; Torchio, M.* ; Medeiros-Domingo, A.* ; Simone, S.* ; Will, M.L.* ; Dagradi, F.* ; Schwartz, P.J.* ; Ackerman, M.J.*

Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: Implications for genetic testing.

J. Am. Coll. Cardiol. 60, 1410-1418 (2012)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Objectives The aim of this study was to provide the spectrum and prevalence of mutations in the 12 Brugada syndrome (BrS)-susceptibility genes discovered to date in a single large cohort of unrelated BrS patients. Background BrS is a potentially lethal heritable arrhythmia syndrome diagnosed electrocardiographically by coved-type ST-segment elevation in the right precordial leads (V-1 to V-3; type 1 Brugada electrocardiographic [ECG] pattern) and the presence of a personal/family history of cardiac events. Methods Using polymerase chain reaction, denaturing high-performance liquid chromatography, and DNA sequencing, comprehensive mutational analysis of BrS1-through BrS12-susceptibility genes was performed in 129 unrelated patients with possible/probable BrS (46 with clinically diagnosed BrS [ECG pattern plus personal/family history of a cardiac event] and 83 with a type 1 BrS ECG pattern only). Results Overall, 27 patients (21%) had a putative pathogenic mutation, absent in 1,400 Caucasian reference alleles, including 21 patients with an SCN5A mutation, 2 with a CACNB2B mutation, and 1 each with a KCNJ8 mutation, a KCND3 mutation, an SCN1Bb mutation, and an HCN4 mutation. The overall mutation yield was 23% in the type 1 BrS ECG pattern-only patients versus 17% in the clinically diagnosed BrS patients and was significantly greater among young men <20 years of age with clinically diagnosed BrS and among patients who had a prolonged PQ interval. Conclusions We identified putative pathogenic mutations in similar to 20% of our BrS cohort, with BrS genes 2 through 12 accounting for <5%. Importantly, the yield was similar between patients with only a type 1 BrS ECG pattern and those with clinically established BrS. The yield approaches 40% for SCN5A-mediated BrS (BrS1) when the PQ interval exceeds 200 ms. Calcium channel-mediated BrS is extremely unlikely in the absence of a short QT interval.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Brugada Syndrome ; Cardiac Arrest ; Genetic Testing ; St-segment Elevation ; Ventricular Arrhythmias; SUDDEN CARDIAC DEATH; ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; J-WAVE SYNDROMES; QT-SYNDROME; CHANNEL VARIANTS; ARRHYTHMIAS; SUSCEPTIBILITY; CHANNELOPATHIES; MODULATION
ISSN (print) / ISBN 0735-1097
e-ISSN 1558-3597
Zeitschrift Journal of the American College of Cardiology
Quellenangaben Band: 60, Heft: 15, Seiten: 1410-1418 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort New York, NY
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Human Genetics (IHG)